Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
Accesswire
*STONY BROOK, NY / ACCESSWIRE / May 10, 2024 / *Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader..
Department of Biotechnology
News and Video Search Results
News coverage
-
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Accesswire
-
Infinitopes' Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
PR Newswire Asia
-
Mycocycle Raises $3.6 Million to Transform Waste into Sustainable Raw Materials with Fungi
GlobeNewswire
-
Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility
EQS Group
0 shares
1 views
You might like
Department of Biotechnology media coverage
Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
GlobeNewswire
*Preliminary data detailed in an ASGCT oral presentation include results for one of the youngest children in the world to receive a..
-
Gynecology Collaboration, R&D, and Licensing Deals Trends Report 2024
GlobeNewswire
-
Stem Cell Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 162 Agreements Signed Since 2016
GlobeNewswire
-
Antibiotic Collaboration and Licensing Deals Analysis Report 2024 with Directory of 133 Agreements Signed Since 2019
GlobeNewswire
-
599 Cancer Monoclonal Antibody Collaboration and Licensing Deals Report and Directory 2016-2024
GlobeNewswire
Advertisement
More coverage
ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer
GlobeNewswire
· Leveraging profound knowledge in radiopharmaceutical drug development and commercial planning, Dr. Meyrick will lead the medical..
-
HKTDC launches International Healthcare Week
ACN Newswire
-
Yee Hop Holdings' (1662.HK) Subsidiary APEL Triumphs with Three Medals at the International Exhibition of Inventions Geneva
ACN Newswire
-
TAR-200 monotherapy shows greater than 80 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
GlobeNewswire
-
Cancer Biomarkers Market Trends and Global Forecasts, 2024-2035 - Increase in Article Publications Reflect the Rising Interest of Companies in Novel Cancer Biomarkers
GlobeNewswire